TABLE 3.
Vaginal parameters | TX-004HR 4 μg (n = 186) | TX-004HR 10 μg (n = 188) | TX-004HR 25 μg (n = 186) | Placebo (n = 187) | ||||
Vaginal color | ||||||||
Baseline score, mean ± SD | 1.8 ± 0.61 | 1.7 ± 0.59 | 1.8 ± 0.60 | 1.7 ± 0.64 | ||||
LS mean (SE) | n | n | n | n | ||||
Wk 2 | 185 | −0.69 (0.05)a | 187 | −0.77 (0.05)a | 184 | −0.78 (0.05)a | 186 | −0.40 (0.05) |
Wk 6 | 172 | −0.82 (0.05)a | 170 | −0.93 (0.05)a | 173 | −0.89 (0.05)a | 176 | −0.50 (0.05) |
Wk 8 | 164 | −0.98 (0.05)a | 165 | −1.04 (0.05)a | 166 | −0.99 (0.05)a | 167 | −0.50 (0.05) |
Wk 12 | 171 | −0.97 (0.05)a | 173 | −1.06 (0.05)a | 175 | −0.96 (0.05)a | 175 | −0.60 (0.05) |
Vaginal epithelial integrity | ||||||||
Baseline score, mean ± SD | 1.6 ± 0.84 | 1.4 ± 0.83 | 1.5 ± 0.77 | 1.5 ± 0.84 | ||||
LS mean (SE) | n | n | n | n | ||||
Wk 2 | 185 | −0.85 (0.05)a | 187 | −0.87 (0.05)a | 184 | −0.93 (0.05)a | 186 | −0.53 (0.05) |
Wk 6 | 172 | −0.97 (0.05)a | 170 | −1.02 (0.05)a | 173 | −1.01 (0.05)a | 176 | −0.61 (0.05) |
Wk 8 | 164 | −1.03 (0.05)a | 165 | −1.08 (0.05)a | 166 | −1.08 (0.05)a | 167 | −0.66 (0.05) |
Wk 12 | 171 | −0.97 (0.05)a | 173 | −1.07 (0.05)a | 175 | −1.01 (0.05)a | 175 | −0.60 (0.05) |
Vaginal epithelial surface thickness | ||||||||
Baseline score, mean ± SD | 1.9 ± 0.67 | 1.8 ± 0.63 | 1.9 ± 0.59 | 1.9 ± 0.65 | ||||
LS mean (SE) | n | n | n | n | ||||
Wk 2 | 185 | −0.76 (0.05)a | 187 | −0.76 (0.05)a | 184 | −0.76 (0.05)a | 186 | −0.40 (0.05) |
Wk 6 | 172 | −0.85 (0.05)a | 170 | −0.93 (0.05)a | 173 | −0.90 (0.05)a | 176 | −0.53 (0.05) |
Wk 8 | 164 | −0.96 (0.05)a | 165 | −1.04 (0.05)a | 166 | −0.99 (0.05)a | 167 | −0.59 (0.05) |
Wk 12 | 171 | −0.98 (0.05)a | 173 | −1.03 (0.05)a | 175 | −0.94 (0.05)a | 175 | −0.61 (0.05) |
Vaginal secretions | ||||||||
Baseline score, mean ± SD | 1.8 ± 0.68 | 1.7 ± 0.66 | 1.7 ± 0.63 | 1.8 ± 0.63 | ||||
LS mean (SE) | n | n | n | n | ||||
Wk 2 | 185 | −0.79 (0.05)b | 187 | −0.83 (0.05)a | 184 | −0.86 (0.05)a | 186 | −0.54 (0.05) |
Wk 6 | 172 | −0.90 (0.05)b | 170 | −0.95 (0.05)a | 173 | −0.97 (0.05)a | 176 | −0.60 (0.05) |
Wk 8 | 164 | −1.00 (0.05)a | 165 | −1.04 (0.05)a | 166 | −1.06 (0.05)a | 167 | −0.63 (0.05) |
Wk 12 | 171 | −1.01 (0.05)a | 173 | −1.06 (0.05)a | 175 | −1.04 (0.05)a | 175 | −0.64 (0.05) |
Data are mean ± SD unless otherwise noted.
LS, least square; SD, standard deviation; SE, standard error.
aP < 0.0001 versus placebo; bP < 0.001.